Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.
Top 5 Consumer Stocks That May Rocket Higher This Quarter
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
